GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targetable Immune Evasion Pathways in Hodgkin Lymphoma

$362,197
Margaret A Shipp · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils

$362,196
Xin Lu · University Of Notre Dame · R01 · FY2025 · CA

Novel Targeted Therapeutics for Breast Cancer

$362,163
Bulent Ozpolat · Methodist Hospital Research Institute · R01 · FY2023 · CA

Effects of Radiation on Brain Microvasculature and Cognition

$362,161
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2009 · NS

Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate Cancer

$362,142
Brett Stewart Carver · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Improving epidermal growth factor receptor-targeted of HNSCC by inhibition of tr

$362,136
Atul Bedi · Johns Hopkins University · P50 · FY2015 · DE

Bispecific T cell engagers for the treatment of pancreatic ductal adenocarcinoma

$362,118
Nathan G. Dolloff · Leukogene Therapeutics, Inc. · R41 · FY2021 · CA

Integrated Genomic-Transcriptomic Characterization to Identify Molecular Mechanisms of Disparities in PDAC Outcomes

$362,050
Vikas Dudeja · University Of Alabama At Birmingham · R21 · FY2024 · CA

Role of HIV in acceleration of HPV malignancy

$362,043
Sharof M Tugizov · University Of California, San Francisco · R01 · FY2022 · CA

Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression

$362,043
Hideho Okada · University Of California, San Francisco · R01 · FY2022 · CA

Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors

$362,043
Andrei Goga · University Of California, San Francisco · R01 · FY2022 · CA

Non-essential amino acids and sphingolipid diversity in cancer progression

$362,020
Christian Michael Metallo · University Of California, San Diego · R01 · FY2019 · CA

Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology

$362,020
Rohit Bhargava · University Of Illinois At Urbana-Champaign · R33 · FY2018 · CA

Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer

$362,016
Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer

$362,016
Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Imaging the stem cell niche in regeneration and cancer

$362,000
Tannishtha Reya · Duke University · R01 · FY2009 · HL

Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment

$361,987
John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2008 · CA

Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment

$361,987
John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2008 · CA

Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery

$361,974
Marxa L. Figueiredo · Purdue University · R01 · FY2016 · CA

Neuroimmunomodulation within the eye

$361,969
Andrew W Taylor · Boston University Medical Campus · R01 · FY2010 · EY

Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils

$361,953
Xin Lu · University Of Notre Dame · R01 · FY2023 · CA

Role of exosomal SPHK1 in ovarian cancer progression

$361,942
Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2025 · CA

Improving epidermal growth factor receptor-targeted of HNSCC by inhibition of tr

$361,939
Atul Bedi · Johns Hopkins University · P50 · FY2016 · DE

Innate and Adaptive Anti-Myeloma Immunity

$361,924
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2014 · CA

Heat shock proteins in cancer and signaling

$361,867
Boston University Medical Campus · R01 · FY2005 · CA